New option: targeting RNase J and RNase HI in the fight against multi-drug-resistant tuberculosis
Priyatam Khadka, Januka Thapaliya
Annals of Medicine and Surgery · 2024-03
Abstract
aTribhuvan University, Trichandra Multiple Campus, Kirtipur, Nepal bState University of New York, Upstate Medical University, Syracuse, NY Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article Published online ■ ■ *Corresponding author. Address: Tribhuvan University, Trichandra Multiple Campus, Kirtipur, Nepal. E-mail: [email protected] (P. Khadka). This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0/
MeSH terms
- Medicine
- Tuberculosis
- RNase P
- Drug
- RNase H
- Pharmacology
- Virology